Scientific Submissions

The abstract must be submitted as follows:

There is no limit to the number of abstracts an author may submit; however, an author may only serve as the presenting author on two submissions. It is the authors’ responsibility to designate a new presenter for presentation scheduling conflicts that arise. If accepted, the presenter must be a co-author listed on the abstract at the time of submission.

It is mandatory that the presenting author of any abstract accepted for presentation or discussion attends the 61st EASD Annual Meeting 2025 in Vienna to present and discuss his/her paper. Failure to do so, without prior or adequate explanation sent to the EASD Office by e-mail, may result in the author or the institution being banned from presenting abstracts for the next three years.

Abstracts are welcome from non-members of EASD. Please refer to the Registration section, regarding the date by which authors must become members of EASD in order to qualify for preferential registration fees. These regulations will be strictly enforced.

The abstract must be submitted in English. New submitters/authors should create a MyEASD account. With these access credentials, they can revise the submission as often as required, make changes, additions, amendments, change/add/delete authors, copy special characters easily into the text, re-write the abstract or copy and paste the text in the corresponding boxes. All this is possible until the late-breaking Abstract Submission Deadline: 17 June 2025 18:00 hrs CEST. After this date the submission site will be closed.

Always double check that the “complete” status of your submitted abstract has not been affected after having edited it.

Changes to the content and/or author block of the submitted abstract will not be accepted after the submission deadline.

Your abstract submission must adhere the following structure:

• The maximum number of characters is 3,200 (excl. spaces) including the title and the author block. The title should be short (maximum 170 characters).
• Please enter your name and the names of co-authors as given in the example below. Start each name with a capital letter and continue in lower case, do not enter names/affiliations all in capital letters.
  First Name: John
  2nd Initial:  J
  3rd Initial:   R
  Last Name: Macleod
• The abstract must be structured. Enter each section into the corresponding text field with the provided sub-headings in bold (Background and aims, Materials and methods, Results and Conclusion). The abstract structuring words are fixed for each abstract text box. One or two sentences should describe the methods, and any aspects of methodology (e.g. use of control groups, randomisation, patient selection, assay variation). The sentences stating the results must include hard data, including statistical analysis. The abstract requires solid data, i.e. n, p-values and confidence intervals if appropriate.
• It is allowed to include only one table OR one graph to your abstract, but 400 characters will be deducted from the maximum number of characters allowed. Tables must be uploaded as an image; so you must create your table and convert it into an image in order to include it in your abstract. You can edit your table or graph and then replace it, or delete it until the submission deadline on 17 June 2025, 18:00 hrs CEST. Do not enter both (a table and a graph) in the same image file; also, do not create and upload multi panel images (a maximum of two panels is allowed). When creating a table, do not exceed a number of 10 columns and 12 rows with a maximum of 1 line per row!
• References are not allowed.
• For drugs exclusively generic names should be used (no trademarks).
• A list of approved abbreviations and units of expression for use without definition appears in Diabetologia.
• Grant/Support information must be entered in its designated field, not in the abstract body.
• Where applicable, the Clinical Trial Registration Number must be entered into its designated field, not in the abstract body.
• Only one keyword can be selected.
• Abstracts CANNOT be submitted as an e-mail attachment.

Once all submission steps have been successfully completed and the abstract deadline has passed, a notification confirming the final version of the abstract submission will be posted on the presenting author’s Scientific Submission portal (accessible by loging into MyEASD). All notifications will be posted ONLY on the presenting = first named author’s Scientific Submission portal, the name, middle name, last name and e-mail contact used during the submission process must match any existing EASD membership and/or MyEASD account (only one e-mail address per presenting = first named author).

In case of questions, or if no notification confirming the final version of the abstract submission has been received by 25 June 2025, please contact the EASD office: abstracts@easd.org

Keywords

One keyword from the list available here must be selected for the submission.